Atlas Trials

Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients

Clinical trial NCT01995513 · COMPLETED

Trial details

NCT number
NCT01995513
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2013-10-22
Primary completion
2016-11-15
Enrollment
509

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.